A Chinese court’s order to freeze 2.14 billion yuan (US$318 million) in Nexperia-affiliated assets has cemented the operational independence of its Chinese manufacturing engine from its European headquarters, leaving its local facilities increasingly isolated amid a prolonged custody battle.
The Dongguan Intermediate People’s Court in the southern province of Guangdong, where Nexperia’s biggest assembly and test plant is located, has frozen the equity interests in four subsidiaries owned by the…
Comments